Literature DB >> 12149220

Living T9 glioma cells expressing membrane macrophage colony-stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a "paraptosis"-induced pathway that promotes systemic immunity against intracranial T9 gliomas.

Yijun Chen1, Thomas Douglass, Edward W B Jeffes, Qingcheng Xu, Christopher C Williams, Neary Arpajirakul, Christina Delgado, Michael Kleinman, Ramon Sanchez, Qinghong Dan, Ronald C Kim, H Terry Wepsic, Martin R Jadus.   

Abstract

Cloned T9-C2 glioma cells transfected with membrane macrophage colony-stimulating factor (mM-CSF) never formed subcutaneous tumors when implanted into Fischer rats, whereas control T9 cells did. The T9-C2 cells were completely killed within 1 day through a mechanism that resembled paraptosis. Vacuolization of the T9-C2 cell's mitochondria and endoplasmic reticulum started within 4 hours after implantation. By 24 hours, the dead tumor cells were swollen and terminal deoxynucleotide transferase-mediated dUTP nick-end labeling (TUNEL)-positive. Bcl2-transduced T9-C2 cells failed to form tumors in rats. Both T9 and T9-C2 cells produced cytokine-induced neutrophil chemoattractant that recruited the granulocytes into the tumor injection sites, where they interacted with the tumor cells. Freshly isolated macrophages killed the T9-C2 cells in vitro by a mechanism independent of phagocytosis. Nude athymic rats treated with antiasialo GM1 antibody formed T9-C2 tumors, whereas rats treated with a natural killer cell (NK)-specific antibody failed to form tumors. When treated with antipolymorphonuclear leukocyte (anti-PMN) and antimacrophage antibodies, 80% of nude rats formed tumors, whereas only 40% of the rats developed a tumor when a single antibody was used. This suggests that both PMNs and macrophages are involved in the killing of T9-C2 tumor cells. Immunocompetent rats that rejected the living T9-C2 cells were immune to the intracranial rechallenge with T9 cells. No vaccinating effect occurred if the T9-C2 cells were freeze-thawed, x-irradiated, or treated with mitomycin-C prior to injection. Optimal tumor immunization using mM-CSF-transduced T9 cells requires viable tumor cells. In this study optimal tumor immunization occurred when a strong inflammatory response at the injection of the tumor cells was induced.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12149220     DOI: 10.1182/blood-2002-01-0174

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  The thioxotriazole copper(II) complex A0 induces endoplasmic reticulum stress and paraptotic death in human cancer cells.

Authors:  Saverio Tardito; Claudio Isella; Enzo Medico; Luciano Marchiò; Elena Bevilacqua; Maria Hatzoglou; Ovidio Bussolati; Renata Franchi-Gazzola
Journal:  J Biol Chem       Date:  2009-06-26       Impact factor: 5.157

Review 2.  Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.

Authors:  Maria Letizia Ciavatta; Florence Lefranc; Marianna Carbone; Ernesto Mollo; Margherita Gavagnin; Tania Betancourt; Ramesh Dasari; Alexander Kornienko; Robert Kiss
Journal:  Med Res Rev       Date:  2016-12-07       Impact factor: 12.944

3.  Wilms' tumor 1 silencing decreases the viability and chemoresistance of glioblastoma cells in vitro: a potential role for IGF-1R de-repression.

Authors:  Mike Y Chen; Aaron J Clark; Dana C Chan; Joy L Ware; Shawn E Holt; Archana Chidambaram; Helen L Fillmore; William C Broaddus
Journal:  J Neurooncol       Date:  2010-09-04       Impact factor: 4.130

4.  Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death.

Authors:  Lei Wang; Yang Yu; Dar-Chone Chow; Fei Yan; Chih-Chao Hsu; Fabio Stossi; Michael A Mancini; Timothy Palzkill; Lan Liao; Suoling Zhou; Jianming Xu; David M Lonard; Bert W O'Malley
Journal:  Cancer Cell       Date:  2015-08-10       Impact factor: 31.743

Review 5.  Immunotherapy of brain cancers: the past, the present, and future directions.

Authors:  Lisheng Ge; Neil Hoa; Daniela A Bota; Josephine Natividad; Andrew Howat; Martin R Jadus
Journal:  Clin Dev Immunol       Date:  2011-03-08

6.  Regenerative therapeutic potential of adipose stromal cells in early stage diabetic retinopathy.

Authors:  Gangaraju Rajashekhar; Ahmed Ramadan; Chandrika Abburi; Breedge Callaghan; Dmitry O Traktuev; Carmella Evans-Molina; Raj Maturi; Alon Harris; Timothy S Kern; Keith L March
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

7.  Generation of glucagon-like peptide-2-expressing Saccharomyces cerevisiae and its improvement of the intestinal health of weaned rats.

Authors:  Zhongwei Zhang; Xiaodong Wu; Lili Cao; Zhengdong Zhong; Yan Zhou
Journal:  Microb Biotechnol       Date:  2016-09-19       Impact factor: 5.813

Review 8.  Neutrophils: New Critical Regulators of Glioma.

Authors:  Guanyu Wang; Jinpeng Wang; Chaoshi Niu; Yan Zhao; Pengfei Wu
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

9.  Molecular mechanisms of paraptosis induction: implications for a non-genetically modified tumor vaccine.

Authors:  Neil Hoa; Michael P Myers; Thomas G Douglass; Jian Gang Zhang; Christina Delgado; Lara Driggers; Linda L Callahan; Gerald VanDeusen; Jimmy T H Pham; Nirav Bhakta; Lisheng Ge; Martin R Jadus
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.